$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Which one is more effective, cabozantinib or abiraterone?
2026-02-01 22:25:32
Check Details
What common targeted therapies does cabozantinib interact with?
2026-02-01 22:25:32
Check Details
Does cabozantinib have an effect on phosphocarcinoma?
2026-02-01 22:25:32
Check Details
What is the recommended dose of cabozantinib in patients with lung adenocarcinoma?
2026-02-01 22:25:32
Check Details
How effective is cabozantinib in the treatment of advanced lung cancer?
2026-02-01 22:25:32
Check Details
How many times a day should patients with lung cancer take cabozantinib?
2026-02-01 22:25:32
Check Details
Instructions for Midostaurin
2026-02-01 22:25:32
Check Details
What are the precautions for using midostaurin?
2026-02-01 22:25:32
Check Details
Instructions for Livdelzi (Seladelpar)
2026-02-01 22:25:32
Check Details
What are the precautions for Livdelzi (Seladelpar)
2026-02-01 22:25:32
Check Details
What medicine is Livdelzi (Seladelpar)?
2026-02-01 22:25:32
Check Details
How effective is Livdelzi (Seladelpar)?
2026-02-01 22:25:32
Check Details
1
2
...
977
978
979
980
981
982
983
...
10223
10224
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Eltrombopag Administration Timing and Alternative Therapy Guide
2
Osimertinib Safety Guide: Foods to Avoid, Mechanism of Action, and Pre-Treatment Warnings
3
Avatrombopag: A Complete Guide to Dosage, Mechanism, and Clinical Use
4
Tazemetostat Dosage Guide: Laos Generic vs. Original Tazverik Comparison
5
Tivozanib: A Next-Generation Highly Selective VEGFR-Targeted Therapy Explained
6
Capmatinib Clinical Guide: Drug Comparisons, Treatment Strategies, and Combination Therapy Prospects
7
Avatrombopag Complete Guide: Efficacy, Indications, and TPO-RA Drug Comparisons
8
Pralsetinib Clinical Guide: Discontinuation Principles, Drug Comparisons, and Treatment Strategies
9
Venetoclax Clinical Guide: Mechanism, Indications, and Originator vs. Generic Comparison
10
Dabrafenib Clinical Guide: Indications, Combination Strategies, and BRAF Inhibitor Comparisons
11
Elagolix Side Effects and Safety Guide
12
Hetrombopag vs. Avatrombopag: Key Differences Between Two Oral TPO-RAs and Safety Considerations